Aortic atherosclerotic disease and stroke.
Kronzon
Itzhak
I
Charles and Rose Wohlstetter Noninvasive Cardiology Laboratory, New York University School of Medicine, 560 1st Ave, New York, New York 10016, USA.
Tunick
Paul A
PA
D000925:Anticoagulants / Q000627:therapeutic use; D001018:Aortic Diseases / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D050197:Atherosclerosis / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D001281:Atrial Fibrillation / Q000150:complications; D018438:Blue Toe Syndrome / Q000150:complications; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D003952:Diagnostic Imaging / Q000009:adverse effects / Q000379:methods; D004617:Embolism / Q000209:etiology; D004691:Endarterectomy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007049:Iatrogenic Disease; D020766:Intracranial Embolism / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D012307:Risk Factors; D020521:Stroke / Q000209:etiology*; D014652:Vascular Diseases / Q000150:complications / Q000175:diagnosis / Q000473:pathology
D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors